AU Stock MarketDetailed Quotes

PER Percheron Therapeutics Ltd

Watchlist
  • 0.100
  • 0.0000.00%
20min DelayMarket Closed Oct 2 16:00 AET
90.15MMarket Cap-7142P/E (Static)

Percheron Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
Operating cash flow (direct method)
Cash income from operating activities
-11.44%1.58M
211.93%1.78M
-18.50%571K
4.36%700.6K
135.64%671.34K
284.9K
Income from government grants
----
----
----
----
--30.1K
----
Other cash income from operating activities
-11.44%1.58M
211.93%1.78M
-18.50%571K
9.26%700.6K
125.08%641.24K
--284.9K
Cash paid
-19.40%-12.28M
-22.69%-10.28M
-28.37%-8.38M
-40.77%-6.53M
-41.05%-4.64M
-3.29M
Payments to suppliers for goods and services
-19.40%-12.28M
-22.69%-10.28M
-28.37%-8.38M
-40.77%-6.53M
-41.05%-4.64M
---3.29M
Direct interest paid
55.81%-3.6K
31.53%-8.15K
-10.94%-11.91K
14.37%-10.73K
---12.54K
----
Direct interest received
64.05%587.23K
2,055.90%357.97K
265.73%16.6K
-86.46%4.54K
-55.12%33.52K
--74.69K
Operating cash flow
-24.10%-10.12M
-4.44%-8.15M
-33.78%-7.81M
-47.87%-5.83M
-34.73%-3.95M
---2.93M
Investing cash flow
Cash flow from continuing investing activities
87.69%-3.61K
-648.56%-29.29K
53.13%-3.91K
18.64%-8.35K
-100.43%-10.26K
2.4M
Net PPE purchase and sale
87.69%-3.61K
-648.56%-29.29K
53.13%-3.91K
18.64%-8.35K
---10.26K
----
Net investment purchase and sale
----
----
----
----
----
--2.4M
Cash from discontinued investing activities
Investing cash flow
87.69%-3.61K
-648.56%-29.29K
53.13%-3.91K
18.64%-8.35K
-100.43%-10.26K
--2.4M
Financing cash flow
Cash flow from continuing financing activities
13,017.17%11.02M
-100.41%-85.3K
169.39%21.02M
52.66%7.8M
233.45%5.11M
1.53M
Net common stock issuance
--11.11M
----
167.58%21.1M
51.38%7.89M
239.84%5.21M
--1.53M
Net other financing activities
-4.79%-89.39K
-7.38%-85.3K
3.57%-79.44K
15.84%-82.39K
---97.89K
----
Cash from discontinued financing activities
Financing cash flow
13,017.17%11.02M
-100.41%-85.3K
169.39%21.02M
52.66%7.8M
233.45%5.11M
--1.53M
Net cash flow
Beginning cash position
-42.98%10.97M
219.47%19.23M
48.31%6.02M
39.81%4.06M
52.89%2.9M
--1.9M
Current changes in cash
110.88%899.4K
-162.56%-8.27M
573.79%13.21M
69.65%1.96M
15.07%1.16M
--1M
End cash Position
8.20%11.87M
-42.98%10.97M
219.47%19.23M
48.31%6.02M
39.81%4.06M
--2.9M
Free cash from
-23.70%-10.12M
-4.76%-8.18M
-33.66%-7.81M
-47.70%-5.84M
-35.08%-3.96M
---2.93M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019
Operating cash flow (direct method)
Cash income from operating activities -11.44%1.58M211.93%1.78M-18.50%571K4.36%700.6K135.64%671.34K284.9K
Income from government grants ------------------30.1K----
Other cash income from operating activities -11.44%1.58M211.93%1.78M-18.50%571K9.26%700.6K125.08%641.24K--284.9K
Cash paid -19.40%-12.28M-22.69%-10.28M-28.37%-8.38M-40.77%-6.53M-41.05%-4.64M-3.29M
Payments to suppliers for goods and services -19.40%-12.28M-22.69%-10.28M-28.37%-8.38M-40.77%-6.53M-41.05%-4.64M---3.29M
Direct interest paid 55.81%-3.6K31.53%-8.15K-10.94%-11.91K14.37%-10.73K---12.54K----
Direct interest received 64.05%587.23K2,055.90%357.97K265.73%16.6K-86.46%4.54K-55.12%33.52K--74.69K
Operating cash flow -24.10%-10.12M-4.44%-8.15M-33.78%-7.81M-47.87%-5.83M-34.73%-3.95M---2.93M
Investing cash flow
Cash flow from continuing investing activities 87.69%-3.61K-648.56%-29.29K53.13%-3.91K18.64%-8.35K-100.43%-10.26K2.4M
Net PPE purchase and sale 87.69%-3.61K-648.56%-29.29K53.13%-3.91K18.64%-8.35K---10.26K----
Net investment purchase and sale ----------------------2.4M
Cash from discontinued investing activities
Investing cash flow 87.69%-3.61K-648.56%-29.29K53.13%-3.91K18.64%-8.35K-100.43%-10.26K--2.4M
Financing cash flow
Cash flow from continuing financing activities 13,017.17%11.02M-100.41%-85.3K169.39%21.02M52.66%7.8M233.45%5.11M1.53M
Net common stock issuance --11.11M----167.58%21.1M51.38%7.89M239.84%5.21M--1.53M
Net other financing activities -4.79%-89.39K-7.38%-85.3K3.57%-79.44K15.84%-82.39K---97.89K----
Cash from discontinued financing activities
Financing cash flow 13,017.17%11.02M-100.41%-85.3K169.39%21.02M52.66%7.8M233.45%5.11M--1.53M
Net cash flow
Beginning cash position -42.98%10.97M219.47%19.23M48.31%6.02M39.81%4.06M52.89%2.9M--1.9M
Current changes in cash 110.88%899.4K-162.56%-8.27M573.79%13.21M69.65%1.96M15.07%1.16M--1M
End cash Position 8.20%11.87M-42.98%10.97M219.47%19.23M48.31%6.02M39.81%4.06M--2.9M
Free cash from -23.70%-10.12M-4.76%-8.18M-33.66%-7.81M-47.70%-5.84M-35.08%-3.96M---2.93M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg

No Data